In silico Therapeutics

In silico therapeutics made possible

Algorithm379 is a global biopharmaceutical company discovering and developing innovative therapeutics for the immune and metabolic diseases. Our major focus is RNA and protein based therapeutics as well as novel drug formulations for small molecules. We are also exploring how  the repurposing of the existing drugs can help deliver better precision medicine solutions to the patients.

The paradigm shift in drug discovery and therapeutics development requires the combination of cheminformatics, bioinformatics and advanced omics based data analytics. We focus on our client needs to offer bespoke solutions.


We help with the early target identification, evaluation and preparation for high-throughput screening. By integrating public, proprietary and client data we can uncover the real therapeutic potential.

We offer tailor-made solutions using the state-of-the-art AI/ML discoveries to speed up target identification and compound screens. This also extends to modeling patient data and assisting medical professionals in their decision making.